share_log

At US$91.00, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

At US$91.00, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

在91美元的价格下,美国物理治疗公司(纽交所:USPH)值得密切关注吗?
Simply Wall St ·  08/06 07:37

U.S. Physical Therapy, Inc. (NYSE:USPH), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$108 at one point, and dropping to the lows of US$90.75. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether U.S. Physical Therapy's current trading price of US$91.00 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at U.S. Physical Therapy's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

U.S. Physical Therapy, Inc.(纽交所:USPH)虽然不是大盘股,但近几个月在纽交所上出现了 substantial 的价格波动,一度上涨至 108 美元,最低跌至 90.75 美元。有些股价波动可以让投资者以较低的价格进入股票,并有潜力以较低价格买入。需要回答的一个问题是,U.S. Physical Therapy 目前的交易价格 91.00 美元反映了该小市值股票的实际价值吗?或者目前被低估,为我们提供了买入的机会?让我们根据最新的财务数据研究 U.S. Physical Therapy 的前景和价值,看看是否有任何触发价格变化的因素。

What's The Opportunity In U.S. Physical Therapy?

U.S. Physical Therapy 的机会在哪里?

According to our price multiple model, where we compare the company's price-to-earnings ratio to the industry average, the stock currently looks expensive. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. We find that U.S. Physical Therapy's ratio of 77.84x is above its peer average of 25.97x, which suggests the stock is trading at a higher price compared to the Healthcare industry. If you like the stock, you may want to keep an eye out for a potential price decline in the future. Since U.S. Physical Therapy's share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

根据我们的价格倍增模型,在该模型中,我们将公司的市盈率与行业平均值进行比较,现在的股票看起来是昂贵的。在这种情况下,我们使用了市盈率,因为没有足够的信息可靠地预测股票的现金流。我们发现 U.S. Physical Therapy 的市盈率为 77.84 倍,超过了同行业的平均市盈率 25.97 倍,这表明该股票正在以较高的价格交易相比于医疗保健行业。如果你喜欢这支股票,你可能需要留意未来潜在的价格下跌。由于 U.S. Physical Therapy 的股价相当波动,这可能意味着它未来可能会下跌(或上涨),我们还有另一个投资机会。这基于其高 beta 值,beta 值也是衡量某只股票相对于整个市场波动性的一个好指标。

What does the future of U.S. Physical Therapy look like?

U.S. Physical Therapy 的未来如何?

big
NYSE:USPH Earnings and Revenue Growth August 6th 2024
纽约证券交易所(NYSE):USPH 股票收益和营业收入增长于 2024 年 8 月 6 日

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. U.S. Physical Therapy's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.

如果投资者正在寻找其组合中的成长性,也许在购买其股票之前考虑公司前景会更好。以一个便宜的价格购买一个前景有看好的优秀公司股票始终是一个好投资,因此让我们也来看看公司的未来预期。U.S. Physical Therapy 的收益在未来几年内有望翻一番,预示着一个非常乐观的未来。这应该会导致更强的现金流,反过来又会推动股票价值的提高。

What This Means For You

这对您意味着什么?

Are you a shareholder? USPH's optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. At this current price, shareholders may be asking a different question – should I sell? If you believe USPH should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

你是股东吗?USPH 的乐观增长前景似乎已经被纳入了当前股价,股票交易在行业价值倍数之上。在当前价格下,股东们可能会问一个不同的问题——我应该卖出吗?如果你认为 USPH 价格应该低于当前价格,那么在其价格降至行业市盈率时高价卖出,然后再买回来是可以盈利的。但在做出这个决定之前,请看看其基本面是否有变化。

Are you a potential investor? If you've been keeping an eye on USPH for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the optimistic prospect is encouraging for USPH, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.

你是潜在投资者吗?如果你一直关注 USPH,现在可能不是进入该股票的最佳时机。价格已经超过了同行业的股票,这意味着可能没有更多的误价上涨空间,但是乐观的前景仍然值得深入挖掘其他因素以利用下一次价格下跌。

So while earnings quality is important, it's equally important to consider the risks facing U.S. Physical Therapy at this point in time. In terms of investment risks, we've identified 5 warning signs with U.S. Physical Therapy, and understanding them should be part of your investment process.

因此,虽然收益质量很重要,但同时也要考虑当前时点 U.S. Physical Therapy 面临的风险。就投资风险而言,我们已经确定了与 U.S. Physical Therapy 相关的 5 个警告标志,了解这些标志应该是你投资过程中的一部分。

If you are no longer interested in U.S. Physical Therapy, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果你已经不再对 U.S. Physical Therapy 感兴趣,你可以使用我们的免费平台查看我们的超过 50 只增长潜力高的股票列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发